BME’s External Advisory Board (EAB) provides broad perspectives

The U-M Biomedical Engineering Department’s External Advisory Board (BME EAB) is a distinguished group of alumni and friends of the department who are committed to BME’s goal of solving important challenges in medicine and the life sciences to the benefit of humanity. 

The BME EAB provides advice and support on key departmental priorities including: the student experience, research excellence, clinical translation, diversity, and alumni and industry engagement and meets bi-annually to discuss strategic priorites and opportunities for BME at Michigan. 

External Advisory Board 2023-2024

Samuel Achilefu, Ph.D.

Professor and Lyda Hill Distinguished University Chair in Biomedical Engineering 

University of Texas Southwestern Medical Center

Victoria Augustine, M.S.E.*

Acting Director, Office of Patent Automation (OPA), United States Patent and Trademark Office (USPTO); Supervisory Patent Examiner,


Robert DeRyke, M.B.A.

President and CEO,

Terumo Cardiovascular Group Executive Officer,

Terumo Corporation

Caroline Dugopolski, M.S.*

Caroline Dugopolski

VP of Program Management, Quality and Technical Operations,


David Knapp, Ph.D.*

Vice President R&D, Vascular

Boston Scientific

President, Boston Scientific Foundation

Scott Merz, Ph.D.*

President and CEO,

MC3 Cardiopulmonary

Aftin Ross, Ph.D.*

Deputy Division Director

Division of All Hazards Response, Science and Strategic Partnerships (DARSS),

Office of Strategic Partnerships & Technology Innovation (OST),

Center for Devices and Radiological Health

U.S. Food and Drug Administration

Jason Weidman, M.B.A.*

SVP and President

Coronary & Renal Denervation


Erin West Farrell, Ph.D.*

Director, Toxins Strategic Projects


Desmond Yeo, Ph.D.

Technology Manager 

MRI & Superconducting Magnets Technology & Innovation Center (R&D)

GE Healthcare

* Denotes U-M Alum